Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer

The predictive values of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) gene expressions were retrospectively evaluated in patients with gastric cancer treated by a regimen containing S-1. The study population consisted of 53 patients registered into different two phase II studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, W, Takahashi, T, Suto, K, Yamashita, T, Nihei, Z, Shirota, Y, Shimizu, M, Sasaki, Y, Hirayama, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409894/
https://www.ncbi.nlm.nih.gov/pubmed/15354215
http://dx.doi.org/10.1038/sj.bjc.6602139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409894/
https://www.ncbi.nlm.nih.gov/pubmed/15354215
http://dx.doi.org/10.1038/sj.bjc.6602139

Ejemplares similares